NCT01275625 - Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

July 31, 2013

Conditions

HIV

Interventions

DRUG

HIV therapy

Combivir one tablet BD with maraviroc 300mg BD for 48 weeks

Trial Locations (8)

Federal scientific and methodological center on AIDS prophylaxis and control, Moscow

Moscow regional center on AIDS and infectious diseases prophylaxis and control, Moscow

Saint-Petersburg Center on AIDS and Infectious Diseases Prophylaxis and Control, Saint Petersburg

Federal State Institution Republican clinical infectious hospital of Roszdrav, Saint Petersburg

Smolensk Center on AIDS and infectious diseases prophylaxis and control, Smolensk

Volgograd Regional Center on AIDS and Infectious Diseases Prophylaxis and Control, Volgograd

Regional Center on AIDS and Infectious Diseases Prophylaxis and Control, Nizhny Novgorod

Regional Center on AIDS and Infectious Diseases Prophylaxis and Control, Krasnoyarsk